The global intelligence OS for pain medicine –
connecting 14 countries through one unified platform
PIN is not a registry. It is a data-powered, physician-governed operating system for the world's most underserved chronic disease · enhanced with a pharmacovigilance layer that makes it the only real-world platform where clinical outcomes and drug safety data live in the same longitudinal dataset. Regulators, payers, and pharma sponsors have been waiting for this for decades.
| Revenue Stream | Model | Yr 1 | Yr 2 | Yr 3 | Status |
|---|---|---|---|---|---|
ASM Implementation Setup White-glove clinic onboarding | $10K-$12K/clinic | $1.0M-$1.2M | $2.5M-$3.6M | $7.5M-$12M | Primary |
Patient Follow-Up PMPM Between-visit monitoring + app engagement | $8-$15 PMPM | $200K-$450K | $1.2M-$2.7M | $2.4M-$5.4M | Ramp |
Platform Subscriptions Clinic software license + ASM workflows | Annual clinic license | $100K-$240K | $300K-$720K | $900K-$2.4M | Primary |
Premium Memberships + CME AAPM/PIN education and member tools | $200-$300/yr individual | $80K | $220K | $600K | Live |
Research Registry Access De-identified data for academia/industry | Per-study fee | $80K | $350K | $1.5M | Live |
PASS / PMS Study Fees Post-authorization safety studies | $50K-$150K/study | - | $400K | $1.6M | Phase 2 |
PV + Payer AI Licensing Signal detection, payer analytics, opioid risk API | SaaS + API | - | $440K | $3.2M | Phase 2 |
- Co-branded AAPM distribution path
- 1,000+ MD channel; 100-clinic launch pool; 10-25 initial conversions
- $10K-$12K white-glove implementation per clinic/location
- $8-$15 PMPM patient follow-up economics
- $1M-$1.2M gross implementation upside if 100 clinics convert
- Grow from 100-clinic upside to 250-300 clinic pipeline
- $2.5M-$3.6M setup sales potential at $10K-$12K/clinic
- $8-$15 PMPM follow-up expands recurring revenue base
- PV SaaS + PASS studies remain secondary expansion streams
- 750-1,000 clinic scale target across U.S. and global channels
- $7.5M-$12M setup sales potential before recurring PMPM
- Full PV platform, payer analytics, and 8+ pharma clients
- Government / EMA / FDA / Health Canada contract pathway
Pain Medicine is at an Inflection Point
CMS's Ambulatory Specialty Model turns pain physicians into accountable-risk operators starting Jan 2027, creating an urgent buyer inside a $624B total burden / $40B direct-spend beachhead for the intelligence platform that gets practices audit-ready.
- → CMS ASM holds individual physicians — not hospitals — accountable for episode cost and outcomes
- → Any group managing 20+ Medicare LBP episodes/yr in a launch market must comply — not optional
- → Specialists drive most CMS spending growth — pain is the pilot for MSK, cancer, and mental health next
- → Payment risk escalates from 9% to 12% of Part B revenue between 2027 and 2031
First-Mover Advantage
PIN is the only platform designed specifically for pain medicine with built-in pharmacovigilance, multi-site research capabilities, and payer analytics in a single integrated OS.
Join the Global Intelligence Revolution in Pain Medicine
PIN is positioned to become the standard global data infrastructure for pain medicine—connecting 14 countries, a 1,000+ physician AAPM-enabled channel, and CMS compliance-grade risk data in a single, unified platform. The window for early participation is closing.
For investor inquiries, contact:
investors@paininnovation.net